Typhoid conjugate vaccine demonstrates strong safety and immunogenicity in Phase III trial

Phase III results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj. Multi-dose, demonstrate that it ...
MedPage Today

Antibody-Drug Conjugate Shows Benefits in HER2-Positive Early Breast Cancer

The addition of neoadjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved pathologic complete response (pCR) ...
Pulmonology Advisor

Efficacy of 20-Valent Pneumococcal Conjugate Vaccine Wanes With Increasing Patient Age

The vaccine effectiveness of PCV20 against IPD and all-cause pneumonia was highest among individuals aged 65 to 74 years and decreased with increasing age.

Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

This data is encouraging as it reinforces the large and growing body of evidence indicating that certepetide can enhance the targeting, penetration, and effectiveness of therapeutic agents - in this ...
China Daily Global Edition

First domestically developed 13-valent pneumonia vaccine released

Chinese drugmaker Walvax Biotechnology Co Ltd announced on Tuesday that the first batch of its 13-valent pneumococcal ...

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate ...